Accessibility Menu
 
Aroa Biosurgery logo

Aroa Biosurgery

(ASX) ARX

Current Price$0.61
Market Cap$217.92M
Since IPO (2020)-59%
5 Year-47%
1 Year+43%
1 Month+6%

Aroa Biosurgery Financials at a Glance

Market Cap

$217.92M

Revenue (TTM)

$100.35M

Net Income (TTM)

$3.18M

EPS (TTM)

$-0.00

P/E Ratio

-131.25

Dividend

$0.00

Beta (Volatility)

0.13 (Low)

Price

$0.61

Volume

385,335

Open

$0.63

Previous Close

$0.63

Daily Range

$0.61 - $0.64

52-Week Range

$0.43 - $0.80

ARX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aroa Biosurgery

Industry

Biotechnology

CEO

Brian Roderick Ward, PhD, MBA

Headquarters

Auckland, 2022, NZ

ARX Financials

Key Financial Metrics (TTM)

Gross Margin

85%

Operating Margin

0%

Net Income Margin

-2%

Return on Equity

-2%

Return on Capital

0%

Return on Assets

-2%

Earnings Yield

-0.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$217.92M

Shares Outstanding

345.90M

Volume

385.33K

Avg. Volume

155.44K

Financials (TTM)

Gross Profit

$65.99M

Operating Income

$8.13M

EBITDA

$2.65M

Operating Cash Flow

$2.33M

Capital Expenditure

$3.36M

Free Cash Flow

$5.69M

Cash & ST Invst.

$20.13M

Total Debt

$5.83M

Aroa Biosurgery Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$41.08M

+129.7%

Gross Profit

$35.37M

+128.0%

Gross Margin

86.11%

N/A

Market Cap

$217.92M

N/A

Market Cap/Employee

$798.24K

N/A

Employees

273

N/A

Net Income

$1.19M

+20.8%

EBITDA

$1.61M

+208.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$14.57M

+6.2%

Accounts Receivable

$30.49M

+27.5%

Inventory

$7.09M

-15.7%

Long Term Debt

$5.02M

-7.8%

Short Term Debt

$1.12M

+33.8%

Return on Assets

-1.74%

N/A

Return on Invested Capital

0.15%

N/A

Free Cash Flow

$3.19M

+208.5%

Operating Cash Flow

$3.64M

+263.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OCC.AXOrthocell Limited
$0.91+1.68%
TTX.AXTetratherix Ltd.
$4.80+1.69%
AVH.AXAVITA Medical, Inc.
$1.20-1.23%
MVF.AXMonash IVF Group Limited
$0.74+1.37%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$12.91+0.04%
SOFISoFi Technologies
$16.10+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About ARX

What is the current price of Aroa Biosurgery?

Aroa Biosurgery is trading at A$0.61 per share.

What is the 52-week range for Aroa Biosurgery?

Over the past 52 weeks, Aroa Biosurgery has traded between A$0.43 and A$0.80.

How much debt does Aroa Biosurgery have?

As of the most recent reporting period, Aroa Biosurgery reported total debt of $5.83M.

How much cash does Aroa Biosurgery have on hand?

Aroa Biosurgery reported $7.26M in cash and cash equivalents in its most recent financial results.

What is Aroa Biosurgery’s dividend yield?

Aroa Biosurgery does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.